NuVasive (NASDAQ:NUVA) reported Q1 EPS of $0.54, $0.15 better than the analyst estimate of $0.39. Revenue for the quarter came in at $290.8 million versus the consensus estimate of $277.97 million.
GUIDANCE:
NuVasive sees FY2022 EPS of $2.15-$2.45, versus the consensus of $2.17.